Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity (Q44980793)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

7 December 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity (English)

1 reference

7 December 2017

1 reference

8

1 reference

7 December 2017

Suresh Radhakrishnan

1

1 reference

7 December 2017

Loc Tan Nguyen

2

1 reference

7 December 2017

Bogoljub Ciric

3

1 reference

7 December 2017

Dallas Flies

4

1 reference

7 December 2017

Virginia P Van Keulen

5

1 reference

7 December 2017

Koji Tamada

6

1 reference

7 December 2017

Lieping Chen

7

1 reference

7 December 2017

Larry R Pease

9

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

64

1 reference

7 December 2017

issue

14

1 reference

7 December 2017

page(s)

4965-4972

1 reference

Expression of programmed death 1 ligands by murine T cells and APC

7 December 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4049/JIMMUNOL.169.10.5538

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Correction of Defects Responsible for Impaired Qa-2 Class Ib MHC Expression on Melanoma Cells Protects Mice from Tumor Growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells

2 references

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

30 December 2023

https://opencitations.net/index/api/v1/citations/10.4049/JIMMUNOL.170.4.1830

Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4 T cells independent of the PD-1 receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Activation of human dendritic cells through CD40 cross-linking.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4 T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Type 1 and type 2 CD8 effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25( ) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

NK and CD8 T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.

2 references

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1084/JEM.20021466

Dendritic cells and the control of immunity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Human CD4 T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Spinning molecular immunology into successful immunotherapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Decreased tumor surveillance in perforin-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-03-3025

Identifiers

DOI

10.1158/0008-5472.CAN-03-3025

1 reference

7 December 2017

1 reference